Multicenter Acute Stroke Trial-Europe "MAST-E"

Completed

Phase 3 Results

Summary of Purpose

To assess the efficacy and safety of streptokinase in patients with acute ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 21 September 2000.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

Double-blind, controlled trial of 310 patients at 48 centers in France and the UK.

Contacts

Not available